ClinicalTrials.gov
public full text
Public Domain
SLV308 for Treatment of Patients With Parkinson's Disease Experiencing Motor Fluctuations
This study is a multicenter, randomized, double blind, parallel group study of 3 months' treatment with SLV308 administered as a monotherapy in patients with advance stage PD. An open label safety extension to this study is planned as a separate protocol for patients who are willing and eligible to participate.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Behavioural Profiling of Disease-related Cognitive and Motor Impairment in PD#1045668
- VG081821AC Tablets for Early to Mid-stage Parkinson's Disease#881731
- A Long-Term Extension Trial From of SPM 962 in Advanced Parkinson's Disease Patients#833795
- A Long-term, Phase 3 Study of TVP-1012 (1 mg) in Levodopa Treated Parkinson's Disease Participants#1293040
- A Long-Term Extension Trial From Phase II/III of SPM 962 in Early Parkinson's Disease Patients#855651
Record · ID 1259569
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive